172 related articles for article (PubMed ID: 29981755)
1. An Integrated Data Resource for Genomic Analysis of Cutaneous T-Cell Lymphoma.
Chang LW; Patrone CC; Yang W; Rabionet R; Gallardo F; Espinet B; Sharma MK; Girardi M; Tensen CP; Vermeer M; Geskin LJ
J Invest Dermatol; 2018 Dec; 138(12):2681-2683. PubMed ID: 29981755
[No Abstract] [Full Text] [Related]
2. Overview of Cutaneous T-Cell Lymphomas.
Larocca CA; LeBoeuf NR
Hematol Oncol Clin North Am; 2019 Aug; 33(4):669-686. PubMed ID: 31229162
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma.
Scarisbrick JJ; Whittaker S; Evans AV; Fraser-Andrews EA; Child FJ; Dean A; Russell-Jones R
Blood; 2001 Feb; 97(3):624-30. PubMed ID: 11157477
[TBL] [Abstract][Full Text] [Related]
4. Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p.
Scarisbrick JJ; Woolford AJ; Russell-Jones R; Whittaker SJ
J Invest Dermatol; 2001 Sep; 117(3):663-70. PubMed ID: 11564174
[TBL] [Abstract][Full Text] [Related]
5. Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma.
Kamstrup MR; Gjerdrum LM; Biskup E; Lauenborg BT; Ralfkiaer E; Woetmann A; Ødum N; Gniadecki R
Blood; 2010 Oct; 116(14):2504-12. PubMed ID: 20538790
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
7. Using molecular biologic analysis of T-cell receptor gene rearrangements to stage cutaneous T-cell lymphoma.
Wood GS
Arch Dermatol; 1998 Feb; 134(2):221-3. PubMed ID: 9487215
[No Abstract] [Full Text] [Related]
8. Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome.
Caprini E; Bresin A; Cristofoletti C; Helmer Citterich M; Tocco V; Scala E; Monopoli A; Benucci R; Narducci MG; Russo G
Cell Death Dis; 2018 Dec; 9(12):1178. PubMed ID: 30518749
[TBL] [Abstract][Full Text] [Related]
9. bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas.
Garatti SA; Roscetti E; Trecca D; Fracchiolla NS; Neri A; Berti E
Recent Results Cancer Res; 1995; 139():249-61. PubMed ID: 7597296
[TBL] [Abstract][Full Text] [Related]
10. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.
Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR
J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392
[TBL] [Abstract][Full Text] [Related]
11. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas.
Mao X; Orchard G; Lillington DM; Russell-Jones R; Young BD; Whittaker SJ
Blood; 2003 Feb; 101(4):1513-9. PubMed ID: 12393503
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.
Ungewickell A; Bhaduri A; Rios E; Reuter J; Lee CS; Mah A; Zehnder A; Ohgami R; Kulkarni S; Armstrong R; Weng WK; Gratzinger D; Tavallaee M; Rook A; Snyder M; Kim Y; Khavari PA
Nat Genet; 2015 Sep; 47(9):1056-60. PubMed ID: 26258847
[TBL] [Abstract][Full Text] [Related]
13. Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sézary syndrome and role of the bmi-1 and ras oncogenes in disease progression.
Zhang C; Toulev A; Kamarashev J; Qin JZ; Dummer R; Döbbeling U
Hum Pathol; 2007 Jul; 38(7):995-1002. PubMed ID: 17442375
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characterization and genomic aberrations in subcutaneous panniculitis-like T-cell lymphoma.
Hahtola S; Burghart E; Jeskanen L; Karenko L; Abdel-Rahman WM; Polzer B; Kajanti M; Peltomäki P; Pettersson T; Klein CA; Ranki A
J Invest Dermatol; 2008 Sep; 128(9):2304-9. PubMed ID: 18337827
[TBL] [Abstract][Full Text] [Related]
15. Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma.
Weng WK; Armstrong R; Arai S; Desmarais C; Hoppe R; Kim YH
Sci Transl Med; 2013 Dec; 5(214):214ra171. PubMed ID: 24307695
[TBL] [Abstract][Full Text] [Related]
16. Variants of mycosis fungoides and related cutaneous T-cell lymphomas.
LeBoit PE
Semin Diagn Pathol; 1991 May; 8(2):73-81. PubMed ID: 1871452
[No Abstract] [Full Text] [Related]
17. Epigenetics of Cutaneous T-Cell Lymphomas.
Hara N; Sawada Y
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408897
[TBL] [Abstract][Full Text] [Related]
18. A new molecular paradigm in mycosis fungoides and Sézary syndrome.
Elenitoba-Johnson KS; Wilcox R
Semin Diagn Pathol; 2017 Jan; 34(1):15-21. PubMed ID: 28024703
[TBL] [Abstract][Full Text] [Related]
19. TOX expression in different subtypes of cutaneous lymphoma.
Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
[TBL] [Abstract][Full Text] [Related]
20. Appearance of isochromosome 18q can be associated with in vitro immortalization of human T lymphocytes.
Kaltoft K; Pedersen CB; Hansen BH; Thestrup-Pedersen K
Cancer Genet Cytogenet; 1995 May; 81(1):13-6. PubMed ID: 7773952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
